Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Sales

Burning Rock Biotech (BNR) EBT Margin: 2020-2024

Historic EBT Margin for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to 66.06%.

  • Burning Rock Biotech's EBT Margin rose 1903.00% to 12.51% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.78%, marking a year-over-year increase of 6418.00%. This contributed to the annual value of 66.06% for FY2024, which is 5513.00% up from last year.
  • Per Burning Rock Biotech's latest filing, its EBT Margin stood at 66.06% for FY2024, which was up 45.49% from 121.19% recorded in FY2023.
  • Burning Rock Biotech's 5-year EBT Margin high stood at 66.06% for FY2024, and its period low was 172.08% during FY2022.
  • Its 3-year average for EBT Margin is 119.78%, with a median of 121.19% in 2023.
  • Per our database at Business Quant, Burning Rock Biotech's EBT Margin crashed by 6,197bps in 2021 and then skyrocketed by 5,513bps in 2024.
  • Over the past 5 years, Burning Rock Biotech's EBT Margin (MRY) stood at 94.73% in 2020, then plummeted by 65bps to 156.70% in 2021, then dropped by 10bps to 172.08% in 2022, then increased by 30bps to 121.19% in 2023, then soared by 45bps to 66.06% in 2024.
  • Its EBT Margin was 66.06% in FY2024, compared to 121.19% in FY2023 and 172.08% in FY2022.